466 related articles for article (PubMed ID: 27911314)
1. Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis.
Anstey KJ; Ashby-Mitchell K; Peters R
J Alzheimers Dis; 2017; 56(1):215-228. PubMed ID: 27911314
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis.
Anstey KJ; Lipnicki DM; Low LF
Am J Geriatr Psychiatry; 2008 May; 16(5):343-54. PubMed ID: 18448847
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum TC and LDL-C levels in Alzheimer's disease and mild cognitive impairment: A meta-analysis study.
Liu Y; Zhong X; Shen J; Jiao L; Tong J; Zhao W; Du K; Gong S; Liu M; Wei M
Brain Res; 2020 Jan; 1727():146554. PubMed ID: 31765631
[TBL] [Abstract][Full Text] [Related]
4. Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study.
Solomon A; Kåreholt I; Ngandu T; Winblad B; Nissinen A; Tuomilehto J; Soininen H; Kivipelto M
Neurology; 2007 Mar; 68(10):751-6. PubMed ID: 17339582
[TBL] [Abstract][Full Text] [Related]
5. Serum cholesterol and risk of Alzheimer disease: a community-based cohort study.
Li G; Shofer JB; Kukull WA; Peskind ER; Tsuang DW; Breitner JC; McCormick W; Bowen JD; Teri L; Schellenberg GD; Larson EB
Neurology; 2005 Oct; 65(7):1045-50. PubMed ID: 16217057
[TBL] [Abstract][Full Text] [Related]
6. Serum thyroid-stimulating hormone as a predictor of cognitive impairment in an elderly cohort.
Forti P; Olivelli V; Rietti E; Maltoni B; Pirazzoli G; Gatti R; Gioia MG; Ravaglia G
Gerontology; 2012; 58(1):41-9. PubMed ID: 21430364
[TBL] [Abstract][Full Text] [Related]
7. The association between midlife serum high-density lipoprotein and mild cognitive impairment and dementia after 19 years of follow-up.
Svensson T; Sawada N; Mimura M; Nozaki S; Shikimoto R; Tsugane S
Transl Psychiatry; 2019 Jan; 9(1):26. PubMed ID: 30659169
[TBL] [Abstract][Full Text] [Related]
8. Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later.
Solomon A; Kivipelto M; Wolozin B; Zhou J; Whitmer RA
Dement Geriatr Cogn Disord; 2009; 28(1):75-80. PubMed ID: 19648749
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol in mild cognitive impairment and Alzheimer's disease in a birth cohort over 14 years.
Toro P; Degen Ch; Pierer M; Gustafson D; Schröder J; Schönknecht P
Eur Arch Psychiatry Clin Neurosci; 2014 Sep; 264(6):485-92. PubMed ID: 24241689
[TBL] [Abstract][Full Text] [Related]
10. Lipid metabolism in cognitive decline and dementia.
Panza F; D'Introno A; Colacicco AM; Capurso C; Pichichero G; Capurso SA; Capurso A; Solfrizzi V
Brain Res Rev; 2006 Aug; 51(2):275-92. PubMed ID: 16410024
[TBL] [Abstract][Full Text] [Related]
11. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
Farina N; Llewellyn D; Isaac MGEKN; Tabet N
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002854. PubMed ID: 28418065
[TBL] [Abstract][Full Text] [Related]
12. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
Farina N; Llewellyn D; Isaac MG; Tabet N
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
[TBL] [Abstract][Full Text] [Related]
14. Association of Midlife Plasma Amyloid-β Levels With Cognitive Impairment in Late Life: The ARIC Neurocognitive Study.
Sullivan KJ; Blackshear C; Simino J; Tin A; Walker KA; Sharrett AR; Younkin S; Gottesman RF; Mielke MM; Knopman D; Windham BG; Griswold ME; Mosley TH
Neurology; 2021 Sep; 97(11):e1123-e1131. PubMed ID: 34349010
[TBL] [Abstract][Full Text] [Related]
15. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
[TBL] [Abstract][Full Text] [Related]
16. Late-Life Body Mass Index, Rapid Weight Loss, Apolipoprotein E ε4 and the Risk of Cognitive Decline and Incident Dementia.
Bell SP; Liu D; Samuels LR; Shah AS; Gifford KA; Hohman TJ; Jefferson AL
J Nutr Health Aging; 2017; 21(10):1259-1267. PubMed ID: 29188888
[TBL] [Abstract][Full Text] [Related]
17. Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study.
Schilling S; Tzourio C; Soumaré A; Kaffashian S; Dartigues JF; Ancelin ML; Samieri C; Dufouil C; Debette S
PLoS Med; 2017 Mar; 14(3):e1002265. PubMed ID: 28350817
[TBL] [Abstract][Full Text] [Related]
18. Statins and serum cholesterol's associations with incident dementia and mild cognitive impairment.
Beydoun MA; Beason-Held LL; Kitner-Triolo MH; Beydoun HA; Ferrucci L; Resnick SM; Zonderman AB
J Epidemiol Community Health; 2011 Nov; 65(11):949-57. PubMed ID: 20841372
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
